Biological factors responsible for nicotine initiation and dependence are largely unknown. Men and women smoke differently, and may smoke for different reasons. Brain metabolic response to nicotine may explain gender differences in nicotine use. We used FDG-PET to measure brain metabolic response on placebo and following nicotine administered by patch in 42 females and 77 males (smokers and nonsmokers) while performing a Continuous Performance Task (CPT) or the Bushman Competition and Retaliation Task (CRT). Nicotine administration affected brain metabolism much differently in males and females, and these differences were dependent on task and smoking history. In the placebo condition female smokers performing the CPT and female non-smokers performing the CRT consistently had higher brain metabolism than males, especially in the entire prefrontal system and the mid and anterior temporal lobe, language cortices, and related subcortical systems. The overall effect of nicotine was to decrease these gender differences in brain metabolism.
Introduction
Accumulating evidence shows that males and females may smoke at different rates and for different reasons. In general, females take fewer and shorter cigarette puffs, are less sensitive to some of nicotine's effects, are less successful with nicotine replacement therapy, and are more sensitive to smoking cues (CDC, 2003 ; Delfino et al., 2001 ; NIDA, 2000) . We have been interested in the possibility of a gender difference in brain metabolic response to nicotine as a factor in understanding these gender differences. Since we have found a difference in metabolism in response to nicotine between smokers and non-smokers (Fallon et al., 2004) , we also considered gender effects in smokers and non-smokers, both collectively and separately. The imaging tasks included a hostility/retaliatory task and an attentional/impulsivity task given the strong association of these personality characteristics with nicotine susceptibility (Barefoot et al., 1991 ; Fallon et al., 2004 ; Gilbert and Gilbert, 1995 ; Golding and Mangan, 1982 ; Jamner et al., 1999 ; Jenks, 1992 ; Lipkus et al., 1994 ; Netter et al., 1998 ; Scherwitz et al., 1992 ; Whiteman et al., 1997 ; Williams, 1973 ; Zuckerman et al., 1990) . Our hypotheses integrate these findings, proposing an interaction between gender, task, and nicotine.
Methods
Using fluoro-deoxyglucose-position emission tomography (FDG-PET), we contrasted regional brain metabolic response to nicotine patch in smokers and non-smokers while the subjects performed a Continuous Performance Task (CPT) or the Bushman Competition and Retaliatory Task (CRT). Subjects were recruited by advertisement and screened for absence of personal or family major psychiatric illness and absence of medically significant, acute or chronic, illness requiring medication. Smoking history was obtained and subjects having smoked fewer than 10 cigarettes in their life and none in the previous 2 years were classified as non-smokers. Smokers smoked at least 10 cigarettes on a daily basis for at least 1 year and less than two packs per day. In total, 119 subjects participated (77 males and 42 females). Sixty-four nonsmokers completed all PET study procedures with both a placebo and 3.5-mg nicotine patch, and 55 smokers completed the procedures with a placebo, 3.5-mg nicotine patch, and 21-mg nicotine patch. (The 21-mg patch is approximately equivalent to half the plasma level obtained from smoking a standard cigarette.)
We chose a patch delivery of nicotine in nonsmokers in order to remove the cueing and nonnicotine-related effects of smoking. Subjects' levels of brain metabolism with nicotine and placebo were compared in a double-blind, random assignment design. Nicotine (SmithKline Beecham, NicoDerm CQ) was administered at 3.5 or 21 mg, 3.5 h before injection of 5 mCi of FDG. Preliminary pilot testing in nonsmokers demonstrated that some subjects, especially females, developed nausea and vomiting on 7 mg, and most subjects could discern which substance was given (nicotine vs. placebo). The low dose of 3.5 mg minimized both of these potential problems. During the FDG uptake, subjects performed a computer task that required sustained visual attention, response inhibition, and reaction time (CPT) or the Bushman CRT, which involved retaliatory responding by the subjects but not impulsivity-related behaviour (Baker et al., 1995 ; Bushman, 1995 ; Fallon et al., 2004) . In the CPT, the subject views a series of blurred numbers presented a few seconds apart. Target numbers appear at intervals and the subject must remain vigilant to detect these targets with a button press (Nuechterlein et al., 1983) . The Bushman task is used to provoke aggressive, retaliatory responding by participants. The subject competes with an 'opponent ' in a reaction-time task in which the loser receives a blast of unpleasant noise. The object is to determine who can react more quickly to a red signal presented on a computer monitor. The person who presses his/her computer mouse key more slowly receives a burst of white noise while the subject depresses the mouse button delivered through headphones. The subject sets the level of static noise that he/she wants his/her ' opponent' to receive if the opponent's response is slower (a zero intensity level is included to provide a non-aggressive response alternative, and 10 is the most aggressive response. After the trial, the program displays the noise level that the subject's ' opponent' had set for him or her to receive for that trial. For the following trial, the subject can set the loudness and/or the duration of the sound blast to be delivered to the opponent.
Thirty PET slices at 6.5-mm intervals were obtained to cover the entire brain. Differences in regional FDG uptake were analysed by using statistical parametric mapping software (SPM 99 ; Wellcome Department of Cognitive Neurology, University College, London, UK), with voxel values at a threshold of p<0.025 to correct for multiple comparisons, as described in detail by Fallon et al. (2004) . The design matrix included as covariates global metabolic activity, age, handedness, plasma nicotine and cotinine concentrations (Jacob et al., 1981 (Jacob et al., , 2000 to control statistically for the potential effects of these variables. Images were spatially normalized to the SPM standard brain template corresponding to the space defined by the Montreal Neurological Institute (MNI) brain atlas. Coordinates of significant activations were converted from MNI space to the space defined by Talairach and Tournoux to facilitate more widely used anatomical localization nomenclature using a nonlinear combination of two linear transformations (MRC, 2004) . Coordinates above the anterior commissure were transformed using the following three linear equations : Xk=0.9900X, Yk=0.9688Y+0.0460Z, Zk= x0.0485Y+0.9189Z. Coordinates below the anterior commissure where transformed by : Xk=0.9900X, Yk=0.9688Y+0.0420Z, Zk=x0.0485Y+0.8390Z, different transformations were used above and below the AC/PC line because a single transform does not adequately account for the nonlinearity of the match between the Talairach and MNI brain in the dorsal vs. ventral aspects of the brain.
After the initial comparison of males and females on placebo, we separated smokers from non-smokers because of their differential experience with nicotine and our previous studies contrasting smokers and non-smokers (Fallon et al., 2004) . Separate analyses were done for smokers and non-smokers for the CRT and CPT.
Results

Biochemical and behavioural results
There were no gender differences in plasma nicotine and cotinine levels or pre-scan CO measurements or Fagerstrom measures of nicotine dependence (p's>0.36). During the CPT there were no significant differences between males and females on any performance measure (see Table 1 ). During the CRT males increased intensity of retaliation more than females (p<0.05), and females increased duration of retaliation more than males. In post-hoc subgroup analyses the difference between males and females was significant for non-smokers (p<0.02) but not for smokers (p<0.30). Controlling for performance measures did not change the overall PET imaging results. Table 2 ). All of the metabolic differences between males and females reported herein involved higher glucose metabolic rates in females. Most of these differences were bilateral. Regardless of task, in the placebo conditions ( Figure  1a , c) females consistently had higher brain metabolism, especially in the entire prefrontal system and the mid and anterior temporal lobe, language cortices, and related subcortical systems. Although nicotine administration affected metabolism in males and females differently, the overall effect of nicotine was to eliminate the differences between males and females in the CPT (Figure 1b ), but to a lesser degree in the CRT, when non-smokers and smokers are combined ( Figure 1d ).
PET imaging results
Nicotine affected males and females much differently (see Figures 1-3 and
CPT
In non-smokers on the CPT there were few differences in brain metabolism between males and females receiving the placebo patch ( Figure 2a) .
In smokers on the CPT, the differences in brain metabolism between males and females receiving the placebo patch were greatly exaggerated and included sectors of virtually all areas of the brain (Figure 2b and Table 2a ). The metabolic increases in females were concentrated in the cortical and subcortical prefrontal system, i.e. orbital cortex, dorsal prefrontal cortex (the superior and middle frontal gyri), DLPFC (the central two-thirds of the middle frontal gyrus, corresponding to Brodmann area 46), posterior medial thalamus, ventral caudate, nucleus accumbens, anterior cingulate occipital cortex (the latter four out of plane on the figure), and the receptive and premotor language areas. The differences in brain metabolism between male and female smokers were essentially eliminated by both the 3.5-and 21-mg nicotine patches in smokers (Figure 2d ).
In summary, most of the differences in metabolism between males and females while performing the CPT were found in the smokers on placebo. With nicotine, these differences largely disappeared.
CRT
A different pattern is observed with the CRT (Figure 3) . In non-smokers on the CRT, brain metabolism in sectors of virtually all areas of the brain was higher in females while performing the CRT and receiving the placebo patch ( Figure 3a and Table 2b ). These gender differences in brain metabolism in nonsmokers were virtually eliminated by the 3.5-mg nicotine patch (Figure 3c ). In smokers on the CRT, there were very few differences between males and females when receiving placebo ( Figure 3b) ; with nicotine, there were virtually no metabolic differences (Figure 3d ). Post-hoc analyses confirmed that the Gender as a determinant of brain response to nicotine 19 gender differences in response to nicotine is not a consequence of an effect or lack of effect in either gender but rather an interaction between gender, nicotine, and task. Yoshii et al. (1988) , but not Kawachi et al. (2002) , observed higher brain metabolism in females at rest (i.e. no task). Gender differences in brain function have been reported for memory, emotional memory, facial recognition, and visuospatial tasks (Cahill et al., 2001 ; Weiss et al., 2003) , although no such differences have been reported for either the CPT or CRT. The gender differences in effects of nicotine on brain metabolism are largely unstudied, despite reported gender differences in nicotine use. Staley et al. (2001) found higher dopamine and serotonin transporter availability in CPT, females vs. males females and File et al. (2001) found that nicotine decreased negative mood ratings in females and increased them in males. Polymorphisms in the serotonin transporter gene have been linked to depression only in the presence of chronic stress, demonstrating an interaction between the serotonin transporter, mood, and environment (Caspi et al., 2003) . Gender differences have also been reported for depression and hostility. Personality traits are also linked with nicotine dependence/susceptibility (Fallon et al., 2004) .
Discussion
We report higher brain metabolism in females during both the CPT and CRT. Nicotine eliminated the higher brain metabolism seen in females compared to males on placebo during the CPT (Figure 1b) , but not the CRT (Figure 1d ). Combining smokers and nonsmokers, however, is inappropriate because we have shown that smoking history changes brain metabolic response to nicotine (Fallon et al., 2004) . Therefore, once we considered the effects of gender separately in smokers and non-smokers, any gender differences in either smokers or non-smokers that were observed on placebo, with the CPT or CRT, were eliminated or greatly reduced with nicotine. Specifically, with the CPT, higher metabolism was seen in female smokers relative to male smokers, which was eliminated by nicotine. With the CRT, higher metabolism was seen in female non-smokers relative to male non-smokers, which was eliminated by nicotine. The higher metabolism observed with placebo occurred primarily in the prefrontal, temporal, and inferior parietal lobe systems, including those areas involving choice, attention, short-term memory, executive function, mood, and language. These differences were reversed by nicotine.
The results of the present study demonstrate the importance of considering gender in understanding the behavioural, physiological, and brain metabolic effects that are associated with nicotine susceptibility/ dependence in addition to smoking history, and personality traits present at birth. Additionally, it is likely that other genetic factors contribute to susceptibility to nicotine. These results suggest that male and female subjects are differentially susceptible to nicotine based on the rigors imposed by certain tasks, and by implication, certain environments and social situations with attentional and retaliatory demands. Our results may be relevant to understanding the gender differences in smoking behaviours in different environments. 
